ARTICLE | Management Tracks
Zenas names Lisa von Moltke head of R&D and CMO
Plus: CBC’s Lan Kang becomes CEO of Azkarra, and updates from Ionctura, Sunbird and Surf Bio
March 18, 2025 12:57 AM UTC
Lisa von Moltke became head of R&D and CMO of autoimmune company Zenas Biopharma Inc. (NASDAQ:ZBIO), a Waltham, Mass.-based start-up founded by former Tesaro Inc. CEO Lonnie Moulder. von Moltke was CMO of Seres Therapeutics Inc. (NASDAQ:MCRB) and is a veteran of Alkermes plc (NASDAQ:ALKS). Zenas which is advancing obexelimab, a CD19 mAb, became a publicly listed company last year.
Azkarra Therapeutics Inc. hired CBC Group alum Lan Kang as president and CEO. The South San Francisco company is targeting pathways at the intersection of DNA damage repair and immune response...